Dr hafez selim md phd (17 risultati)

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Condizione: New.

Taschenbuch. Condizione: Neu. Neuware.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A practical, evidence-based clinical guide to deciding when hyperbaric oxygen therapy belongs in diabetic foot ulcer care - and when it does not.Hyperbaric oxygen therapy (HBOT) remains one of the most debated adjuncts in advanced wound care. Positive trials and biological rationale coexist with negative modern studies, low-certainty recommendations, treatment burden, and uncommon but serious risks.For clinicians facing a nonhealing foot ulcer, the question is not whether HBOT always works or never works. It is whether this patient is likely to benefit after perfusion, infection control, debridement, offloading, metabolic management, and adequate standard care have been addressed.This clinician-focused guide will help readers:Understand why diabetic foot ulcers fail to heal and where wound hypoxia may contribute.Evaluate randomized trials, systematic reviews, guidelines, and conflicting clinical evidence.Distinguish systemic chamber-delivered HBOT from topical and normobaric oxygen therapies.Identify candidates using Wagner grade, perfusion, treatment response, contraindications, and ability to complete therapy.Plan treatment, measure response, and decide when HBOT should be continued or stopped.Recognize adverse effects, serious risks, and essential hyperbaric medicine safety systems.Practical resources include patient-selection and pretreatment safety criteria, the elements of informed consent, monitoring and adverse-event documentation standards, evidence tables, a patient handout, six teaching cases, and a one-page clinical decision algorithm.Written for wound-care physicians, podiatrists, hyperbaric clinicians, vascular specialists, nurses, researchers, and healthcare trainees, this evidence-based clinical guide connects diabetic wound healing, chronic wound management, and limb preservation with disciplined decision-making.HBOT helps some patients, cannot help most, burdens all, and harms a few. This book provides the framework needed to distinguish those groups - and to use HBOT responsibly without overselling its benefits or ignoring its limitations.…

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - When Medicines Harm: Fifty-One Case Histories That Shaped PharmacovigilanceMost drug-safety rules were written after something went wrong. This book tells the story behind each one.In 1937 an untested solvent in a new antibiotic syrup killed more than 100 people, and the United States began requiring proof of safety before a drug could be sold. In the early 1960s a sedative sold as harmless caused a worldwide epidemic of birth defects, and modern drug regulation followed. In 2004 a blockbuster painkiller was withdrawn over heart risk, and US regulators gained new powers over marketed drugs. Nearly every requirement a drug-safety professional applies today goes back to a specific failure and a specific group of patients.When Medicines Harm collects 51 of those cases. They run from Elixir Sulfanilamide in 1937 to the end of the clozapine safety program in 2025, and include thalidomide, DES, fen-phen, Vioxx, TGN1412, contaminated heparin, Mediator, Pandemrix, nitrosamine impurities, the COVID-19 vaccines and the cough-syrup poisonings of the 2020s. Each chapter follows one case:Where it started: the clinical background and the first signal.Weighing the evidence: the explanations considered at the time and the evidence that finally settled the question.What followed: the regulatory response and what it changed.Built for teaching. Every chapter includes:Two decision points that stop the story at a real moment and ask what you would have done with only the evidence available then.Lessons for practice and discussion questions.Fully referenced sources, including later corrections where they exist.A scoring guide helps readers judge each decision. The epilogue draws out eight lessons that recur across the cases. The appendices summarize all 51 cases in one table, group them by how the harm was first detected, and define the key terms.Written for:Drug-safety physicians and pharmacovigilance scientistsRegulatory affairs professionalsTrainees and students in pharmacy, medicine and public healthAnyone who teaches drug safety through seminars, journal clubs or training programsAbout the author. Dr. Hafez Selim, MD, PhD, is a safety physician at a top-ten global pharmaceutical company. He previously spent nearly a decade in safety roles at a leading medical device company. His other books include Practical Benefit-Risk Assessment in Pharmacovigilance.…

Taschenbuch. Condizione: Neu. When Medicines Harm | Hafez Selim | Taschenbuch | Englisch | 2026 | Dr. Hafez Selim MD, PhD | EAN 9798235219847 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.

Taschenbuch. Condizione: Neu. Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers | Safety, Effectiveness, Patient Selection, and Clinical Limitations | Hafez Selim | Taschenbuch | Englisch | 2026 | Dr. Hafez Selim MD, PhD | EAN 9798237887198 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. …

Taschenbuch. Condizione: Neu. Practical Benefit-Risk Assessment in Pharmacovigilance From Safety Signals to Regulatory Decisions | Hafez Selim | Taschenbuch | Englisch | 2026 | Dr. Hafez Selim MD, PhD | EAN 9798237377460 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering.